EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -21.17 Million EUR | -607.26% |
| 2022 | -2.93 Million EUR | -519.0% |
| 2021 | 700 Thousand EUR | 141.08% |
| 2020 | -1.7 Million EUR | -212.7% |
| 2019 | 1.51 Million EUR | 547.34% |
| 2018 | -338 Thousand EUR | 50.37% |
| 2017 | -681 Thousand EUR | -117.73% |
| 2016 | 3.84 Million EUR | 330.47% |
| 2015 | -1.66 Million EUR | -225.59% |
| 2014 | -512 Thousand EUR | 89.8% |
| 2013 | -5.02 Million EUR | 32.83% |
| 2012 | -7.47 Million EUR | -696.91% |
| 2011 | -938 Thousand EUR | 92.62% |
| 2010 | -12.71 Million EUR | -63.75% |
| 2009 | -7.76 Million EUR | -586.29% |
| 2008 | 1.59 Million EUR | 129.37% |
| 2007 | -5.43 Million EUR | -58.51% |
| 2006 | -3.43 Million EUR | -222.5% |
| 2005 | -1.06 Million EUR | 7.32% |
| 2004 | -1.14 Million EUR | 87.19% |
| 2003 | -8.96 Million EUR | -121.61% |
| 2002 | -4.04 Million EUR | -156.55% |
| 2001 | 7.15 Million EUR | -39.1% |
| 2000 | 11.74 Million EUR | 287.9% |
| 1999 | -6.24 Million EUR | 12.75% |
| 1998 | -7.16 Million EUR | -4039.29% |
| 1997 | 181.81 Thousand EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -6.16 Million EUR | -34.1% |
| 2024 Q1 | -4.57 Million EUR | 6.94% |
| 2023 Q4 | -4.91 Million EUR | -24.52% |
| 2023 Q1 | -7.49 Million USD | -45.99% |
| 2023 Q3 | -3.94 Million EUR | 16.01% |
| 2023 FY | -20.74 Million EUR | -607.26% |
| 2023 Q2 | -4.69 Million EUR | 37.28% |
| 2022 Q1 | 357 Thousand EUR | -73.85% |
| 2022 FY | -2.93 Million EUR | -519.0% |
| 2022 Q4 | -5.13 Million EUR | -39569.23% |
| 2022 Q3 | 13 Thousand EUR | -99.29% |
| 2022 Q2 | 1.82 Million EUR | 411.76% |
| 2021 FY | 700 Thousand EUR | 141.08% |
| 2021 Q4 | 1.36 Million EUR | 234.48% |
| 2021 Q3 | -1.01 Million EUR | -139.39% |
| 2021 Q2 | -424 Thousand EUR | -154.85% |
| 2021 Q1 | 773 Thousand EUR | -0.9% |
| 2020 Q3 | -1 Million EUR | -472.0% |
| 2020 Q1 | -1.3 Million EUR | -33.74% |
| 2020 Q2 | -175 Thousand EUR | 86.62% |
| 2020 FY | -1.7 Million EUR | -212.7% |
| 2020 Q4 | 780 Thousand EUR | 177.92% |
| 2019 Q1 | 328 Thousand EUR | -68.25% |
| 2019 Q2 | 1.37 Million EUR | 320.43% |
| 2019 Q4 | -978 Thousand EUR | -139.28% |
| 2019 FY | 1.51 Million EUR | 547.34% |
| 2019 Q3 | 2.49 Million EUR | 80.57% |
| 2018 Q4 | 1.03 Million EUR | 249.28% |
| 2018 FY | -338 Thousand EUR | 50.37% |
| 2018 Q3 | -692 Thousand EUR | 9.78% |
| 2018 Q2 | -767 Thousand EUR | -961.8% |
| 2018 Q1 | 89 Thousand EUR | 197.8% |
| 2017 Q2 | -1.74 Million EUR | -203.93% |
| 2017 Q4 | -91 Thousand EUR | 82.67% |
| 2017 FY | -681 Thousand EUR | -117.73% |
| 2017 Q1 | 1.68 Million EUR | 231.53% |
| 2017 Q3 | -525 Thousand EUR | 69.95% |
| 2016 Q4 | -1.27 Million EUR | -201.35% |
| 2016 FY | 3.84 Million EUR | 330.47% |
| 2016 Q2 | 2.49 Million EUR | 83.68% |
| 2016 Q1 | 1.36 Million EUR | -73.42% |
| 2016 Q3 | 1.26 Million EUR | -49.52% |
| 2015 Q2 | 487 Thousand EUR | 119.96% |
| 2015 Q3 | -4.83 Million EUR | -1091.79% |
| 2015 Q4 | 5.11 Million EUR | 205.92% |
| 2015 FY | -1.66 Million EUR | -225.59% |
| 2015 Q1 | -2.44 Million EUR | 7.51% |
| 2014 Q2 | -5.26 Million EUR | -726.79% |
| 2014 Q3 | 6.55 Million EUR | 224.43% |
| 2014 Q4 | -2.63 Million EUR | -140.27% |
| 2014 Q1 | 840 Thousand EUR | 247.37% |
| 2014 FY | -512 Thousand EUR | 89.8% |
| 2013 Q3 | -373 Thousand EUR | -91.28% |
| 2013 FY | -5.02 Million EUR | 32.83% |
| 2013 Q1 | -3.88 Million EUR | -253.64% |
| 2013 Q4 | -570 Thousand EUR | -52.82% |
| 2013 Q2 | -195 Thousand EUR | 94.98% |
| 2012 Q4 | -1.09 Million EUR | -121.37% |
| 2012 FY | -7.47 Million EUR | -696.91% |
| 2012 Q3 | -496 Thousand EUR | 83.38% |
| 2012 Q1 | -2.89 Million EUR | -401.21% |
| 2012 Q2 | -2.98 Million EUR | -3.0% |
| 2011 Q4 | -578 Thousand EUR | -166.36% |
| 2011 Q2 | -1.44 Million EUR | -777.46% |
| 2011 Q1 | 213 Thousand EUR | 102.95% |
| 2011 FY | -938 Thousand EUR | 92.62% |
| 2011 Q3 | 871 Thousand EUR | 160.36% |
| 2010 FY | -12.71 Million EUR | -63.75% |
| 2010 Q4 | -7.22 Million EUR | -283.03% |
| 2010 Q1 | -2.58 Million EUR | -258.93% |
| 2010 Q2 | -1.01 Million EUR | 60.72% |
| 2010 Q3 | -1.88 Million EUR | -85.45% |
| 2009 Q3 | -5.76 Million EUR | -970.13% |
| 2009 Q1 | -3.08 Million EUR | -185.99% |
| 2009 FY | -7.76 Million EUR | -586.29% |
| 2009 Q4 | 1.62 Million EUR | 128.24% |
| 2009 Q2 | -539 Thousand EUR | 82.55% |
| 2008 Q1 | 1.03 Million EUR | 150.37% |
| 2008 FY | 1.59 Million EUR | 129.37% |
| 2008 Q4 | 3.59 Million EUR | 189.95% |
| 2008 Q3 | -3.99 Million EUR | -499.12% |
| 2008 Q2 | 1 Million EUR | -2.97% |
| 2007 Q1 | -1.19 Million EUR | -4.21% |
| 2007 Q2 | -736.55 Thousand EUR | 38.27% |
| 2007 Q3 | -1.44 Million EUR | -96.37% |
| 2007 FY | -5.43 Million EUR | -58.51% |
| 2007 Q4 | -2.04 Million EUR | -41.49% |
| 2006 Q1 | -620.4 Thousand EUR | -742.84% |
| 2006 Q4 | -1.14 Million EUR | -35.17% |
| 2006 Q3 | -847.05 Thousand EUR | 0.43% |
| 2006 Q2 | -850.68 Thousand EUR | -37.12% |
| 2006 FY | -3.43 Million EUR | -222.5% |
| 2005 Q2 | -408.83 Thousand EUR | -191.19% |
| 2005 Q1 | -140.4 Thousand EUR | 63.19% |
| 2005 FY | -1.06 Million EUR | 7.32% |
| 2005 Q4 | 96.51 Thousand EUR | 116.66% |
| 2005 Q3 | -579.33 Thousand EUR | -41.7% |
| 2004 Q1 | -12.98 Thousand EUR | 99.71% |
| 2004 Q4 | -381.44 Thousand EUR | -49.63% |
| 2004 Q2 | -503.38 Thousand EUR | -3776.17% |
| 2004 FY | -1.14 Million EUR | 87.19% |
| 2004 Q3 | -254.92 Thousand EUR | 49.36% |
| 2003 Q3 | -1.08 Million EUR | 47.8% |
| 2003 Q1 | -1.41 Million EUR | 44.71% |
| 2003 Q2 | -2.07 Million EUR | -46.54% |
| 2003 Q4 | -4.5 Million EUR | -315.37% |
| 2003 FY | -8.96 Million EUR | -121.61% |
| 2002 Q4 | -2.56 Million EUR | -65.29% |
| 2002 FY | -4.04 Million EUR | -156.55% |
| 2002 Q3 | -1.55 Million EUR | -40.46% |
| 2002 Q2 | -1.1 Million EUR | -196.05% |
| 2002 Q1 | 1.15 Million EUR | -81.45% |
| 2001 Q3 | -2.26 Million EUR | -172.38% |
| 2001 Q2 | 3.12 Million EUR | 1567.98% |
| 2001 Q1 | 187.21 Thousand EUR | -98.55% |
| 2001 FY | 7.15 Million EUR | -39.1% |
| 2001 Q4 | 6.2 Million EUR | 374.4% |
| 2000 Q3 | 1.13 Million EUR | 173.56% |
| 2000 Q1 | -701.02 Thousand EUR | 77.83% |
| 2000 Q2 | -1.54 Million EUR | -119.84% |
| 2000 FY | 11.74 Million EUR | 287.9% |
| 2000 Q4 | 12.87 Million EUR | 1035.76% |
| 1999 Q2 | -676.13 Thousand EUR | -142.62% |
| 1999 FY | -6.24 Million EUR | 12.75% |
| 1999 Q1 | -278.68 Thousand EUR | 88.83% |
| 1999 Q4 | -3.16 Million EUR | -47.02% |
| 1999 Q3 | -2.15 Million EUR | -218.16% |
| 1998 Q3 | -4.07 Million EUR | -2136.06% |
| 1998 Q1 | -557.1 Thousand EUR | -147.46% |
| 1998 FY | -7.16 Million EUR | -4039.29% |
| 1998 Q4 | -2.49 Million EUR | 38.73% |
| 1998 Q2 | -182.15 Thousand EUR | 67.3% |
| 1997 Q3 | 450.94 Thousand EUR | 407.98% |
| 1997 Q4 | 1.17 Million EUR | 160.32% |
| 1997 FY | 181.81 Thousand EUR | 0.0% |
| 1997 Q1 | 86.2 Thousand EUR | 0.0% |
| 1997 Q2 | 88.77 Thousand EUR | 2.97% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alphatec Holdings, Inc. | -186.63 Million USD | 88.653% |
| Nemaura Medical Inc. | -14.14 Million USD | -49.734% |
| NeuroPace, Inc. | -32.95 Million USD | 35.739% |
| LENSAR, Inc. | -14.38 Million USD | -47.243% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 59.636% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 64.128% |
| Apyx Medical Corporation | -18.71 Million USD | -13.173% |
| Cutera, Inc. | -162.83 Million USD | 86.994% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -95.549% |
| BioSig Technologies, Inc. | -29.04 Million USD | 27.076% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 65.63% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 131.263% |
| Axonics, Inc. | -6.08 Million USD | -247.865% |
| IRIDEX Corporation | -9.57 Million USD | -121.296% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 80.001% |
| TELA Bio, Inc. | -46.66 Million USD | 54.616% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -156.89% |
| RxSight, Inc. | -48.6 Million USD | 56.431% |
| Align Technology, Inc. | 445.05 Million USD | 104.759% |
| INVO Bioscience, Inc. | -8.03 Million USD | -163.585% |
| electroCore, Inc. | -18.83 Million USD | -12.446% |
| Telesis Bio, Inc. | -47.72 Million USD | 55.624% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 306.756% |
| Quipt Home Medical Corp. | -2.78 Million USD | -660.704% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 74.382% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -87.648% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 59.788% |
| Dynatronics Corporation | -2.69 Million USD | -685.034% |
| Modular Medical, Inc. | -17.47 Million USD | -21.225% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -85.984% |
| Talis Biomedical Corporation | -62 Million USD | 65.846% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -93.313% |
| InMode Ltd. | 197.91 Million USD | 110.7% |
| Envoy Medical, Inc. | -29.9 Million USD | 29.19% |
| Bruker Corporation | 427.2 Million USD | 104.957% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -139.299% |
| DexCom, Inc. | 541.5 Million USD | 103.911% |
| Nexalin Technology, Inc. | -4.64 Million USD | -355.567% |
| PAVmed Inc | -64.17 Million USD | 67.0% |
| Viveve Medical, Inc. | -22.02 Million USD | 3.854% |
| Cerus Corporation | -37.48 Million USD | 43.509% |
| Movano Inc. | -29.28 Million USD | 27.678% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -74.333% |
| Nexalin Technology, Inc. | -4.64 Million USD | -355.567% |
| IceCure Medical Ltd | -14.65 Million USD | -44.54% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 90.487% |
| enVVeno Medical Corporation | -23.51 Million USD | 9.942% |
| 908 Devices Inc. | -36.39 Million USD | 41.817% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 4.124% |
| Orthofix Medical Inc. | -151.39 Million USD | 86.011% |
| Surmodics, Inc. | -11.54 Million USD | -83.486% |
| Nuwellis, Inc. | -20.2 Million USD | -4.795% |
| Outset Medical, Inc. | -172.79 Million USD | 87.744% |
| Venus Concept Inc. | -37.25 Million USD | 43.146% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 82.839% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 57.239% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 65.154% |
| Aethlon Medical, Inc. | -12.2 Million USD | -73.474% |
| Inogen, Inc. | -102.44 Million USD | 79.328% |
| IRadimed Corporation | 17.19 Million USD | 223.18% |
| MaxCyte, Inc. | -37.92 Million USD | 44.155% |
| Pulmonx Corporation | -60.84 Million USD | 65.192% |
| PAVmed Inc. | -64.17 Million USD | 67.0% |
| iCAD, Inc. | -4.84 Million USD | -336.93% |
| OrthoPediatrics Corp. | -20.97 Million USD | -0.973% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 3408.049% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -54.075% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -78.574% |
| SI-BONE, Inc. | -43.33 Million USD | 51.131% |
| Semler Scientific, Inc. | 20.58 Million USD | 202.891% |
| Beyond Air, Inc. | -60.24 Million USD | 64.845% |
| FONAR Corporation | 10.56 Million USD | 300.409% |
| AxoGen, Inc. | -21.71 Million USD | 2.477% |
| Biotricity, Inc. | -14.09 Million USD | -50.26% |
| Cytosorbents Corporation | -28.5 Million USD | 25.711% |
| ZimVie Inc. | -393.28 Million USD | 94.615% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 174.27% |
| Inari Medical, Inc. | -1.63 Million USD | -1194.499% |
| UFP Technologies, Inc. | 44.92 Million USD | 147.142% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 3408.049% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -312.639% |
| Sight Sciences, Inc. | -55.54 Million USD | 61.874% |
| Insulet Corporation | 206.3 Million USD | 110.266% |
| Profound Medical Corp. | -28.56 Million USD | 25.871% |
| Bioventus Inc. | -156.23 Million USD | 86.444% |
| InspireMD, Inc. | -19.91 Million USD | -6.337% |
| BrainsWay Ltd. | -4.19 Million USD | -404.599% |
| BIOLASE, Inc. | -20.63 Million USD | -2.646% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -220.626% |
| Tenon Medical, Inc. | -15.58 Million USD | -35.922% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -37.288% |
| CVRx, Inc. | -41.19 Million USD | 48.596% |
| AdaptHealth Corp. | -678.89 Million USD | 96.881% |
| Sintx Technologies, Inc. | -8.25 Million USD | -156.423% |
| Acutus Medical, Inc. | -81.66 Million USD | 74.067% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -55.915% |
| NanoVibronix, Inc. | -3.71 Million USD | -470.682% |
| Quanterix Corporation | -32.33 Million USD | 34.502% |
| LivaNova PLC | 17.54 Million USD | 220.7% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 40.061% |
| Varex Imaging Corporation | -47.7 Million USD | 55.602% |
| Vivani Medical, Inc. | -25.65 Million USD | 17.441% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -87.648% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 4466.598% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 93.096% |
| TransMedics Group, Inc. | -25.02 Million USD | 15.383% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 4.315% |
| NeuroMetrix, Inc. | -6.52 Million USD | -224.344% |
| Spectral AI, Inc. | -20.85 Million USD | -1.554% |
| Hyperfine, Inc. | -44.23 Million USD | 52.127% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 73.022% |
| Biomerica, Inc. | -5.97 Million USD | -254.266% |
| Bone Biologics Corporation | -8.94 Million USD | -136.659% |
| AVITA Medical, Inc. | -39.16 Million USD | 45.931% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -112.761% |
| Silk Road Medical, Inc | -55.74 Million USD | 62.008% |